Gland Pharma Reports Revenue of INR 14,058 Million in Q2FY25
Gland Pharma has reported a consolidated revenue of INR 14,058 million for Q2 FY25, marking a 2 percent increase compared to INR 13,734 million in Q2 FY24.
Revenue | 05/11/2024 | By Aishwarya
Indegene Achieves Revenue of INR 6,868 Million in Q2FY25
In the second quarter of the financial year 2025, Indegene achieved revenue from operations totaling INR 6,868 million, marking an 8.0 percent Year-over-Year (YoY) growth compared to the same period in the previous year.
Revenue | 29/10/2024 | By Aishwarya | 117
Indegene Achieves Revenue of INR 6,765 Million in First Quarter FY25
Indegene has announced its financial results, achieving revenue of INR 6,765 million in Q1FY25 with growth of 11.4 percent vs Q1FY24.
Revenue | 02/08/2024 | By Aishwarya
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy